Inactivation of CDK/pRb Pathway Normalizes Survival Pattern of Lymphoblasts Expressing the FTLD-Progranulin Mutation c.709-1G>A

• Carolina Alquezar,

  Affiliations Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain, CIBER de Enfermedades Raras (CIBERER), Valencia, Spain

  ⨯
• Noemí Esteras,

  Affiliation Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain

  ⨯
• Ainhoa Alzualde,

  Affiliation Neuroscience Area-Institute Biodonostia, San Sebastian, Spain

  ⨯
• Fermín Moreno,

  Affiliation Department of Neurology, Hospital Donostia, San Sebastian, Spain

  ⨯
• Matilde S. Ayuso,

  Affiliations Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain, CIBER de Enfermedades Raras (CIBERER), Valencia, Spain

  ⨯
• Adolfo López de Munain,

  Affiliations Neuroscience Area-Institute Biodonostia, San Sebastian, Spain, Department of Neurology, Hospital Donostia, San Sebastian, Spain, CIBER de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain

  ⨯
• Ángeles Martín-Requero

  * E-mail: amrequero@cib.csic.es

  Affiliations Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain, CIBER de Enfermedades Raras (CIBERER), Valencia, Spain

  ⨯